Knowledge hub

News

Ardigen – New Corporate Identity

Happy Holidays 2021
Prof. Olivera Finn joined Ardigen’s Scientific Board
Ardigen has received funding for the development of the AI-powered Microbiome Platform.
Gut microbiota’s road to clinical utilization. From bathroom to bedside.
Off-the-Shelf allogeneic cellular immunotherapies for cancer
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
Ardigen obtained a Great Place to Work certification
Current and future directions in CAR-T and TCR-T cell therapies against solid tumors
Blog

Conformal Prediction in Classification

Ardigen and OncoArendi join forces for research collaboration
Cross validation – a safeguard for machine learning models
Machine Learning on its road to conquer Microbiome Research
Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery
Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet
Happy Easter holiday
Reaching beneath the tip of the iceberg: Discovering the potential of TCR-T therapies in treating cancer
DVC – Data Version Control System